PDT Partners’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.85M | Buy |
102,886
+56,479
| +122% | +$1.56M | 0.16% | 220 |
|
|
2025
Q1 | $1.03M | Sell |
46,407
-18,510
| -29% | -$411K | 0.07% | 387 |
|
|
2024
Q4 | $1.28M | Buy |
64,917
+27,675
| +74% | +$547K | 0.11% | 289 |
|
|
2024
Q3 | $931K | Buy |
+37,242
| New | +$931K | 0.08% | 383 |
|
|
2023
Q3 | – | Sell |
-40,439
| Closed | -$569K | – | 637 |
|
|
2023
Q2 | $569K | Hold |
40,439
| – | – | 0.08% | 357 |
|
|
2023
Q1 | $435K | Buy |
40,439
+12,131
| +43% | +$131K | 0.06% | 411 |
|
|
2022
Q4 | $424K | Sell |
28,308
-6,439
| -19% | -$96.5K | 0.07% | 418 |
|
|
2022
Q3 | $446K | Sell |
34,747
-16,632
| -32% | -$213K | 0.07% | 468 |
|
|
2022
Q2 | $498K | Sell |
51,379
-14,897
| -22% | -$144K | 0.04% | 603 |
|
|
2022
Q1 | $659K | Buy |
+66,276
| New | +$659K | 0.06% | 500 |
|